1. Home
  2. TNXP
  3. TNXP News

Latest Tonix Pharmaceuticals Holding Corp. (TNXP) News on December 23, 2024

TNXP

MT Newswires

6 days ago

Tonix Pharmaceuticals Shares Jump After FDA Accepts NDA for Fibromyalgia Drug

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
TNXP

GlobeNewswire

6 days ago

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
TNXP

GlobeNewswire

7 days ago

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
TNXP

ACCESSWIRE

14 days ago

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires
TNXP

GlobeNewswire

20 days ago

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…
TNXP

Zacks Small Cap Research

20 days ago

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments
TNXP

ACCESSWIRE

a month ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

Tonix Pharma Partners for Vaccine Clinical Trial
TNXP

TipRanks

2 months ago

Tonix Pharma Partners for Vaccine Clinical Trial

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
TNXP

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
TNXP

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

Tonix Pharmaceuticals to Present at BIO-Europe® 2024
TNXP

GlobeNewswire

2 months ago

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
TNXP

GlobeNewswire

2 months ago

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
TNXP

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024

TNXP

MT Newswires

2 months ago

Tonix Pharmaceuticals Shares Surge After 1st Payment From Defense Department

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
TNXP

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals
TNXP

GuruFocus.com

2 months ago

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals

TNXP

MT Newswires

2 months ago

Tonix Pharmaceuticals Files New Drug Application With FDA for TNX-102 SL to Treat Fibromyalgia

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
TNXP

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

Tonix Pharma Enhances Drug Development with AI Partnership
TNXP

TipRanks

2 months ago

Tonix Pharma Enhances Drug Development with AI Partnership

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
TNXP

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions
TNXP

ACCESSWIRE

3 months ago

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)
TNXP

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)

TNXP

MT Newswires

3 months ago

Tonix Pharmaceuticals Receives US Patent for Migraine Treatment; Shares Rise

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines
TNXP

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines

Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)
TNXP

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)

TNXP

MT Newswires

3 months ago

Tonix Pharmaceuticals Secures US Patent for Migraine Treatment -- Shares Rise Pre-Bell

Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines
TNXP

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines

New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution
TNXP

ACCESSWIRE

3 months ago

New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution

Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency
TNXP

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
TNXP

ACCESSWIRE

3 months ago

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations
TNXP

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations

TNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization…
TNXP

Zacks Small Cap Research

3 months ago

TNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization…

TNXP

MT Newswires

3 months ago

Tonix Pharmaceuticals Says Mpox Vaccine Effective in Animal Tests

Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta
TNXP

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta

Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL
TNXP

ACCESSWIRE

4 months ago

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)

Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine
TNXP

Benzinga

4 months ago

Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine

Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix’s Mpox Vaccine, TNX-801
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix’s Mpox Vaccine, TNX-801

Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency
TNXP

ACCESSWIRE

4 months ago

Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency

Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)

Tonix initiates Phase II trial for emergency cocaine intoxication treatment
TNXP

Clinical Trials Arena

4 months ago

Tonix initiates Phase II trial for emergency cocaine intoxication treatment

TNXP

MT Newswires

4 months ago

Tonix Pharmaceuticals Begins Phase 2 Trial of Cocaine Intoxication Treatment

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication

TNXP

MT Newswires

4 months ago

Tonix Pharmaceuticals Holding's Q2 Loss Narrows, Revenue Rises

TNXP

MT Newswires

4 months ago

Top Premarket Gainers

Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights

Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests
TNXP

Benzinga

4 months ago

Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests

Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency

Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain
TNXP

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain

Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens

FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate
TNXP

ACCESSWIRE

5 months ago

FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate

Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™

Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain

TNXP

MT Newswires

5 months ago

Tonix Pharmaceuticals Gets FDA Fast Track Label For Tonmya; Shares Rise

Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia

TNXP

MT Newswires

5 months ago

Tonix Pharmaceuticals Signs Deal with US Defense Department to Develop Antiviral Drugs

Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral
TNXP

ACCESSWIRE

5 months ago

Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral

TNXP: High Interest in Tonmya Seen in Initial Findings from Market Opportunity Analysis…
TNXP

Zacks Small Cap Research

5 months ago

TNXP: High Interest in Tonmya Seen in Initial Findings from Market Opportunity Analysis…

TNXP

ACCESSWIRE

5 months ago

Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

TNXP

MT Newswires

5 months ago

Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge

Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering

TNXP

MT Newswires

5 months ago

Tonix Pharmaceuticals Plans Stock Offering; Shares Fall After-Hours

Tonix Pharmaceuticals Announces Proposed Public Offering
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Proposed Public Offering

TNXP

MT Newswires

5 months ago

Tonix Pharmaceuticals Gets FDA Nod to Proceed With New Drug Application for Tonmya in Fibromyalgia

Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia

Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract
TNXP

Benzinga

6 months ago

Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract

Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program

TNXP

MT Newswires

6 months ago

Tonix Pharmaceuticals Closes $4 Million Offering

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

TNXP

MT Newswires

6 months ago

Top Midday Decliners

Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering

Tonix Pharmaceuticals Announces Proposed Public Offering
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Proposed Public Offering

TNXP

MT Newswires

6 months ago

Tonix Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule

Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024

Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia

Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

Tonix Pharmaceuticals Presented Poster of Tonmya™ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Presented Poster of Tonmya™ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

TNXP

MT Newswires

6 months ago

Top Midday Decliners

Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering

TNXP

MT Newswires

6 months ago

Tonix Pharmaceuticals Plans Common Stock Offering to Fund New Drug Application for Fibromyalgia; Shares Fall After Hours

Tonix Pharmaceuticals Announces Proposed Public Offering
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Proposed Public Offering

Edge Total Intelligence Inc. Updates Status of MCTO
TNXP

Newsfile

6 months ago

Edge Total Intelligence Inc. Updates Status of MCTO

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
TNXP

CNW Group

6 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
TNXP

GlobeNewswire

6 months ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting
TNXP

GlobeNewswire

6 months ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
TNXP

GlobeNewswire

6 months ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
TNXP

GlobeNewswire

6 months ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
TNXP

CNW Group

6 months ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
TNXP

PR Newswire

6 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Share on Social Networks: